Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D.

Trial Profile

Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2016

At a glance

  • Drugs Calcitonin (Primary) ; Calcium; Vitamin D analogues
  • Indications Osteoporosis; Postmenopausal osteoporosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Nordic Bioscience
  • Most Recent Events

    • 10 Nov 2012 Planned number of patients changed from 4500 to 4662 as reported by European Clinical Trials Database record.
    • 14 Nov 2011 Primary endpoint 'Vertebral-fractures' has not been met.
    • 14 Nov 2011 Secondary endpoint 'Nonvertebral-fractures' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top